Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 0904-6803

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 0904-6803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 00

Quetiapine extended-release tablets USP 400 mg film-coated tablets, oral dosage form, manufactured by Major Pharmaceuticals. The label indicates a 100-tablet unit dose package, with instructions to dispense with a medication guide and warnings about proper use and storage at controlled room temperature.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 01

Quetiapine extended-release tablets USP 300 mg film-coated tablet label from Major Pharmaceuticals. The unit dose packaging contains 100 tablets for oral use with instructions to swallow whole once daily. The label includes prescription-only status, medication guide dispensing note, manufacturer and distributor details, NDC 0904-6804-61, and storage instructions.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 02

Label for Major Pharmaceuticals Quetiapine extended-release tablets, 200 mg strength. The label indicates these film-coated tablets are for oral use, with directions to take once daily, and highlights that pharmacists should dispense with a medication guide. The package contains 100 tablets and is marked Rx only. Manufacturer and distributor information is included, as well as storage instructions and safety warnings.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 03

Quetiapine 150 mg extended-release film-coated tablets in unit dose packaging by Major Pharmaceuticals. The label indicates oral route, prescription-only status, and includes directions to swallow whole once daily. The package contains 100 tablets and advises pharmacists to dispense with a medication guide. Storage instructions and manufacturer details are provided.*

FDA Label Image

73e2413e 9f47 4ddf 840a C64e6a0ca7bd 04

Quetiapine 50 mg extended-release tablets USP, film-coated, unit dose by Major Pharmaceuticals. The label indicates a 100-tablet count with instructions for once daily use and pharmacist dispensing with medication guide. It includes manufacturer and distributor information, storage conditions, and warnings about use and handling.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 01

Chemical structure of Quetiapine. The image shows the molecular diagram including the bicyclic ring system with sulfur, nitrogen atoms, and ethoxy functional group, along with the associated counter ion structure.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 02

Kaplan-Meier curves illustrating time to schizophrenic relapse in a clinical study, comparing placebo and Quetiapine extended-release (XR). The vertical axis shows the proportion of patients with relapse (%) and the horizontal axis shows time in months up to 7 months. The graph indicates a higher relapse proportion for placebo than for Quetiapine XR over time.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 03

A Kaplan-Meier survival curve graph titled 'Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 9)'. The vertical axis represents the proportion of patients with relapse percentage, ranging from 0 to 100%, and the horizontal axis represents time in weeks, from 0 to 100. Two curves are shown comparing QTP + LIWAL and PLA + LIWAL groups over time.*

FDA Label Image

E3429a09 4870 4e48 9a35 512236e39832 04

A Kaplan-Meier curve graph depicting the proportion of patients with relapse over time in weeks. Two curves represent treatment groups: Quetiapine plus LiVAL and placebo plus LiVAL, showing their respective relapse rates throughout the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.